What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
His primary areas of study are Internal medicine, Endocrinology, Nonalcoholic fatty liver disease, Insulin resistance and Fatty liver.
Internal medicine is closely attributed to Gastroenterology in his work.
His research in Gastroenterology tackles topics such as Genotype which are related to areas like Adiponutrin.
His Endocrinology research incorporates elements of Hemochromatosis, Hereditary hemochromatosis, Inflammation, Case-control study and TM6SF2.
His research integrates issues of Fibrosis, Heterozygote advantage, Chronic liver disease and Type 2 diabetes in his study of Nonalcoholic fatty liver disease.
The Fatty liver study combines topics in areas such as Diabetes mellitus, Liver disease and Lipid droplet.
His most cited work include:
- Genomewide Association Study of Severe Covid-19 with Respiratory Failure. (594 citations)
- Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. (476 citations)
- Homozygosity for the patatin-like phospholipase-3/adiponutrin i148m polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease (455 citations)
What are the main themes of his work throughout his whole career to date?
Luca Valenti spends much of his time researching Internal medicine, Gastroenterology, Fatty liver, Endocrinology and Nonalcoholic fatty liver disease.
His work on Steatosis, Insulin resistance, Cirrhosis and Liver disease as part of general Internal medicine study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His Gastroenterology study incorporates themes from Liver biopsy, Fibrosis, Pathology, Hepatocellular carcinoma and Genotype.
His study in Fatty liver is interdisciplinary in nature, drawing from both Case-control study and Cohort.
His study looks at the intersection of Endocrinology and topics like Hepcidin with Ferritin.
Luca Valenti has researched Nonalcoholic fatty liver disease in several fields, including Liver damage, Lipogenesis, Metabolic syndrome and Type 2 diabetes.
He most often published in these fields:
- Internal medicine (81.80%)
- Gastroenterology (38.56%)
- Fatty liver (36.58%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (81.80%)
- Fatty liver (36.58%)
- Gastroenterology (38.56%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Fatty liver, Gastroenterology, Disease and Steatosis.
Internal medicine connects with themes related to Endocrinology in his study.
His Fatty liver study combines topics in areas such as Cohort and Bioinformatics.
His Gastroenterology study integrates concerns from other disciplines, such as Fibrosis, Autoimmune hepatitis, Risk stratification and Anemia.
He has included themes like Genome-wide association study, Pathophysiology, Type 2 diabetes and Genetic association in his Disease study.
The concepts of his Steatosis study are interwoven with issues in Lipid metabolism, Liver biopsy and Hepatic stellate cell.
Between 2019 and 2021, his most popular works were:
- Genomewide Association Study of Severe Covid-19 with Respiratory Failure. (594 citations)
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. (291 citations)
- COVID-19 and liver disease. (96 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
His main research concerns Internal medicine, Fatty liver, Steatosis, Disease and Steatohepatitis.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Endocrinology and Antibody.
His Fatty liver research integrates issues from Diabetes mellitus, Chronic liver disease, Cirrhosis and Bioinformatics.
His study focuses on the intersection of Steatosis and fields such as Hepatic stellate cell with connections in the field of Macrophage, Receptor, Tyrosine kinase and Hepatic fibrosis.
His work in Disease addresses issues such as Genome-wide association study, which are connected to fields such as Meta-analysis and Locus.
The various areas that Luca Valenti examines in his Steatohepatitis study include Nonalcoholic fatty liver disease and Hepatocyte.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
